In one paragraphArticle in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Emma MartinsBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0000-0002-8298-9566 Belén CuervoBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0000-0002-8104-4560 María Gemma Velasco-MartínezBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0000-0002-0470-9805 Rocío Colomer-SelvaBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.
María Descalzo-NavarroBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0009-0003-2269-252X Beatriz Mena-MorosBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0009-0000-0587-5031 Elena DamiáBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0000-0003-2156-9207 Ángel María Hernández-GuerraBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0000-0002-1771-7214 José-María CarrilloBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.
Mónica RubioBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0000-0002-2689-8862 Joaquín SopenaBiomed Surgery Group (Bioregenerative Medicine and Applied Surgery), Group School Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, C/Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain.ORCID 0000-0002-3601-9745 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Osteoarthritis (OA) is the most prevalent degenerative joint disease in both humans and companion animals, causing progressive cartilage destruction for which no curative treatment currently exists. Plasma rich in growth factors (PRGF) has shown chondroprotective effects in veterinary and preclinical models, but its efficacy is limited by the viscosity of synovial fluid and rapid degradation of growth factors within the joint. This study aimed to evaluate the effect of intra-articular co-administration of PRGF and urease-powered enzymatic nanobots on serum biomarkers of inflammation, oxidative stress, and cartilage metabolism in a rabbit (
Indexed as
C2Cchondral defectFRAPhyaluronic acidnanobotsosteoarthritisoxidative stressPRGFrabbit modelurease
Identifiers
PMID42450717
PMCPMC13359658
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390